MedPlus Health Services Ltd. (MEDPLUS) AI Stock Analysis

• Market Cap: ₹99.31B
• Dividend Yield: N/A
• Average Volume (3M): 39.52K
• Price to Earnings (P/E): 41.8
• Beta (1Y): 0.45
• Revenue Growth: 4.94%
• EPS Growth: 94.22%
• Country: IN
• Employees: 23,415
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 5.30
• Shares Outstanding: 120,054,640
• 10 Day Avg. Volume: 11,750
• 30 Day Avg. Volume: 39,524
• PEG Ratio: 0.46
• Price to Book (P/B): 5.18
• Price to Sales (P/S): 1.47
• P/FCF Ratio: 18.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,155.00
• Price Target Upside: 42.80% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 17.16
• Revenue Forecast (FY): ₹68.47B

• Rating: 62 Neutral
• Price Target: ₹948.00 ▲(17.21% Upside)
• Action: Reiterated Date: 11/04/25
• Date: Action: Reiterated 11/04/25

MedPlus Health Services Ltd. demonstrates strong financial performance with robust cash flow generation and profitability improvements. However, technical indicators suggest potential overbought conditions, and the high P/E ratio indicates overvaluation concerns. The absence of dividend yield further affects its valuation appeal.

Positive Factors

Omnichannel + store network

A large branded-store footprint combined with omnichannel ordering and home delivery creates a durable competitive advantage: it captures repeat chronic prescriptions, broadens catchment beyond walk-ins, raises throughput per store and supports cross-selling, sustaining revenue resilience over months.

Negative Factors

Gross margin compression

A material decline in gross margins is a durable risk: it narrows underwriting buffer against rising procurement, logistics or wage costs and limits ability to expand operating margins. Unless cost structure or product mix improves, profitability remains vulnerable to small shocks.

MedPlus Health Services Ltd. Business Overview & Revenue Model

Company Description

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such ...

Read more

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such ...

How the Company Makes Money

MedPlus generates revenue primarily through the sale of prescription and over-the-counter medications at its retail pharmacy outlets. These pharmacies also sell health and wellness products, which further contribute to its earnings. Additionally, ...

Read more

MedPlus generates revenue primarily through the sale of prescription and over-the-counter medications at its retail pharmacy outlets. These pharmacies also sell health and wellness products, which further contribute to its earnings. Additionally, ...

MedPlus Health Services Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	62.93B	61.36B	56.25B	45.58B	37.79B	30.69B
Gross Profit	13.27B	14.70B	12.14B	9.82B	7.85B	6.38B
EBITDA	4.41B	3.24B	2.08B	1.41B	1.87B	1.52B
Net Income	1.95B	1.50B	654.73M	497.63M	958.02M	638.58M
Balance Sheet
Total Assets	35.72B	33.60B	30.05B	27.97B	25.94B	15.66B
Cash, Cash Equivalents and Short-Term Investments	5.02B	4.40B	1.65B	2.89B	6.58B	1.49B
Total Debt	22.04B	11.20B	10.10B	9.05B	8.15B	5.90B
Total Liabilities	17.28B	16.20B	14.27B	13.06B	11.77B	8.35B
Stockholders Equity	18.45B	17.41B	15.78B	14.91B	14.18B	7.31B
Cash Flow
Free Cash Flow	2.71B	4.95B	593.38M	-785.95M	521.68M	-513.67M
Operating Cash Flow	3.13B	5.54B	1.44B	904.10M	1.70B	28.91M
Investing Cash Flow	-680.55M	-3.32B	-827.99M	4.29B	-7.03B	-345.49M
Financing Cash Flow	-1.22B	-2.28B	-1.98B	-1.70B	4.40B	-56.26M

MedPlus Health Services Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 808.80
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MEDPLUS, the sentiment is Positive. The current price of 808.8 is below the 20-day moving average (MA) of 830.56, below the 50-day MA of 832.22, and below the 200-day MA of 828.34, indicating a bearish trend. The MACD of -3.81 indicates Positive momentum. The RSI at 49.03 is Neutral, neither overbought nor oversold. The STOCH value of 57.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MEDPLUS.

MedPlus Health Services Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VIJAYA	75 Outperform	₹89.39B	63.11	―	0.20%	16.71%	13.92%
HCG	67 Neutral	₹79.29B	-247.47	―	―	17.58%	-38.20%
LALPATHLAB	66 Neutral	₹221.89B	68.44	―	0.89%	10.80%	32.79%
MEDPLUS	62 Neutral	₹99.31B	41.81	―	―	4.94%	94.22%
METROPOLIS	61 Neutral	₹89.37B	60.35	―	0.21%	15.41%	5.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
INDOCO	49 Neutral	₹16.03B	-18.14	―	0.08%	-2.81%	-444.69%

MedPlus Health Services Ltd. Corporate Events